Fulvestrant Plus Palbociclib in Breast Cancer

​Joanne Blum, MD, PhD, FACP

Joanne Blum, MD, PhD, FACP, physician, Texas Oncology, discusses the combination of fulvestrant and palbociclib (Ibrance) in patients with breast cancer, as well as the synergy fulvestrant has with other CDK4/6 inhibitors.